Scientists are investigating the potential of a vaccine that targets nicotine for use in relapse prevention. Studies have shown that a nicotine vaccine is safe and capable of inducing the production of long-lasting antibodies that help prevent smoking relapse. By binding nicotine in the bloodstream and thereby blocking its entry into the brain, the resulting reduction of reinforcing effects is expected to prevent relapse.